Adult Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation: an Observational Study

What this Trial Is About

This observational study focuses on adult patients with type 2 diabetes mellitus who are either on the waiting list for orthotopic liver transplantation (OLT) for at least three months or have already undergone OLT for at least three months. The research aims to gather detailed information on metabolic compensation, patient satisfaction with hypoglycemic treatment, the onset of complications related to diabetes or liver disease, and overall survival. It is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. Participants are observed without any specific intervention, allowing researchers to monitor their natural health progress and treatment satisfaction. The study will primarily measure glycosylated hemoglobin levels over an average follow-up period of five years. Secondary outcomes include evaluating how satisfied patients are with their therapy during this time. During the study, participants will undergo regular assessments to monitor blood sugar control and report their satisfaction with treatment. Researchers will collect data over about five years to evaluate the long-term metabolic control, complications, and survival rates. No experimental treatments are given, and participants continue their usual medical care throughout the observation period.

Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation